Please use this identifier to cite or link to this item: https://doi.org/10.1111/j.1479-8077.2004.00091.x
Title: Improvement in rheumatoid heart disease following infliximab in a patient with long standing rheumatoid arthritis
Authors: Hon, Y.K. 
Keywords: Cardiac failure
Infliximab
Rheumatoid arthritis
Rheumatoid heart disease
Tumour necrosis factor
Issue Date: Sep-2004
Citation: Hon, Y.K. (2004-09). Improvement in rheumatoid heart disease following infliximab in a patient with long standing rheumatoid arthritis. APLAR Journal of Rheumatology 7 (2) : 133-135. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1479-8077.2004.00091.x
Abstract: This report describes a 60-year-old woman with chronic active rheumatoid arthritis (RA) with rheumatoid heart disease treated successfully with infliximab. The patient had a history of rheumatoid heart disease, presented with cardiac failure and also had active polyarthritis. Two-dimensional echocardiogram (2-DE) showed ejection fraction (EF) of 35%. Infliximab therapy at 3 mg/kg was given to the patient, at weeks 0, 2, and 6 and then 8-weekly There was complete remission of her joint symptoms and the EF improved to 55%. Patients with active arthritis and rheumatoid heart disease can benefit from infliximab. ©Asia Pacific League of Associations for Rheumatology.
Source Title: APLAR Journal of Rheumatology
URI: http://scholarbank.nus.edu.sg/handle/10635/130922
ISSN: 02190494
DOI: 10.1111/j.1479-8077.2004.00091.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

21
checked on Nov 8, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.